Checkpoint-Capital-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
14
Total Value
182265533
Accession Number
0001977548-25-000005
Form Type
13F-HR
Manager Name
Checkpoint-Capital-Lp
Data Enrichment
100% identified
14 identified0 unidentified

Holdings

14 positions • $182.3M total value
Manager:
Search and click to pin securities to the top
ARGENX SE
Shares:115.0K
Value:$68.1M
% of Portfolio:37.3% ($68.1M/$182.3M)
RHYTHM PHARMACEUTICALS, INC.
Shares:907.2K
Value:$48.1M
% of Portfolio:26.4% ($48.1M/$182.3M)
Revolution Medicines, Inc.
Shares:392.0K
Value:$13.9M
% of Portfolio:7.6% ($13.9M/$182.3M)
SOLENO THERAPEUTICS INC
Shares:172.9K
Value:$12.4M
% of Portfolio:6.8% ($12.4M/$182.3M)
Disc Medicine, Inc.
Shares:243.3K
Value:$12.1M
% of Portfolio:6.6% ($12.1M/$182.3M)
Protagonist Therapeutics, Inc
Shares:175.2K
Value:$8.5M
% of Portfolio:4.6% ($8.5M/$182.3M)
Stoke Therapeutics, Inc.
Shares:730.7K
Value:$4.9M
% of Portfolio:2.7% ($4.9M/$182.3M)
Septerna, Inc.
Shares:824.9K
Value:$4.8M
% of Portfolio:2.6% ($4.8M/$182.3M)
Kymera Therapeutics, Inc.
Shares:136.6K
Value:$3.7M
% of Portfolio:2.1% ($3.7M/$182.3M)
TScan Therapeutics, Inc.
Shares:2.0M
Value:$2.8M
% of Portfolio:1.5% ($2.8M/$182.3M)
Cidara Therapeutics, Inc.
Shares:104.4K
Value:$2.2M
% of Portfolio:1.2% ($2.2M/$182.3M)
CORCEPT THERAPEUTICS INC
Shares:5.0K
Value:$571.1K
% of Portfolio:0.3% ($571.1K/$182.3M)
Immunocore Holdings plc
Shares:9.0K
Value:$267.4K
% of Portfolio:0.1% ($267.4K/$182.3M)
RAPT Therapeutics, Inc.
Shares:109.8K
Value:$134.0K
% of Portfolio:0.1% ($134.0K/$182.3M)